Factors associated with the presentation of moyamoya in childhood

Catherine Amlie-Lefond1, Richard G Ellenbogen2

  • 1Department of Neurology, Seattle Children's Hospital, University of Washington, Seattle, Washington.

Insights

Moyamoya disease in children often presents with underlying conditions and a history of transient ischemic attacks (TIAs), with Native Americans potentially at higher risk. Early diagnosis is crucial for better outcomes.

Area of Science:

  • Pediatric Neurology
  • Cerebrovascular Diseases
  • Medical Genetics

Background:

  • Moyamoya disease is a leading cause of stroke in children, frequently diagnosed late.
  • Delayed diagnosis occurs even in high-risk groups and despite prior transient ischemic attacks (TIAs).

Purpose of the Study:

  • To identify risk factors and presentation patterns in pediatric moyamoya.
  • To better define at-risk populations for moyamoya disease.

Main Methods:

  • Retrospective chart review of pediatric patients diagnosed with moyamoya.
  • Analysis of patient demographics, medical history, and presenting symptoms.

Main Results:

  • Fifty-four pediatric moyamoya cases identified; mean age 7.5 years, 56% female.
  • 59% had associated predisposing conditions; 31% were of Asian descent; 15% were Native American.
  • 70% had a history of TIAs; 48% presented with stroke; 52% reported headaches.

Conclusions:

  • Most children in this series had predisposing conditions, unlike other US studies.
  • Fewer patients presented with stroke, but more had TIAs, headaches, and Native American heritage.
  • Native American children may represent a higher-risk group for moyamoya disease.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.5K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
549
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
210
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
586
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K